These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33454555)

  • 1. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
    He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
    BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [circ_BACH2 affects the malignant biological behavior of papillary thyroid cancer by regulating miR-370-3p].
    Sun P; Feng Y; Zhou LZ; Pei F; Su B; Qiao XC
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):663-675. PubMed ID: 39034802
    [No Abstract]   [Full Text] [Related]  

  • 7. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
    Chen J; Yin J; Liu J; Zhu RX; Zheng Y; Wang XL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1145-1150. PubMed ID: 30779083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
    Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
    Guo K; Wang J; Shu L; Zhou G
    Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11.
    Song M; Wang N; Li Z; Zhang Y; Zheng Y; Yi P; Chen J
    J Cell Biochem; 2020 Feb; 121(2):984-995. PubMed ID: 31489990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2.
    Wang ZL; Wang C; Liu W; Ai ZL
    Exp Mol Pathol; 2020 Feb; 112():104342. PubMed ID: 31738908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-519d-3p is Associated with Poor Outcomes and Facilitates Tumor Progression in Papillary Thyroid Cancer by Regulating FOXQ1.
    Li P; Pan X; Zheng Z; Sun Y; Han Y; Dong J; Lu M
    Horm Metab Res; 2021 Sep; 53(9):625-632. PubMed ID: 34496413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
    Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
    Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
    Li P; Dong M; Wang Z
    Bosn J Basic Med Sci; 2019 May; 19(2):146-154. PubMed ID: 30114378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma.
    Liu C; Xing M; Wang L; Zhang K
    Br J Biomed Sci; 2017 Apr; 74(2):90-94. PubMed ID: 28367740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.